ImmunityBio, Inc. IBRX 42.5
Health Care · NASDAQ · Data as of 2026-08-04
ImmunityBio, Inc. (IBRX) has delivered +104.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1299 of 1983 stocks overall and #158 of 263 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
42.5
Overall Rank
#1299 / 1983
Sector Rank
#158 / 263
Revenue CAGR
+104.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio